Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

被引：0
作者：
M. Dediu
机构：
[1] Institute of Oncology Bucharest,Medical Oncology Department
来源：
memo - Magazine of European Medical Oncology | 2008年 / 1卷 / 2期
关键词：
Adjuvant chemotherapy; Stage IB; Risk factors; NSCLC;
D O I：
10.1007/s12254-008-0015-4
中图分类号：
学科分类号：
摘要：
Adjuvant chemotherapy is established as a standard of care for resectable non-small cell lung cancer. However, this indication remains controversial for the stage IB as the results of the randomized trials and meta-analysis are obscuring on this issue. Moreover, the updated international guidelines do not prescribe the regular use of this strategy in stage IB. The aim of this paper is to review the current evidences regarding the benefit of adjuvant CT in this setting, and to provide clinical hints, which can lend a helping hand to the clinicians and their patients to take the right decision in this particular scenario.
引用
收藏
页码：61 / 65
页数：4
相关论文
共 50 条
  • [31] Survival and risk model for stage IB non-small cell lung cancer
    Padilla, J
    Calvo, V
    Peñalver, JC
    Zarza, AG
    Pastor, J
    Blasco, E
    París, F
    LUNG CANCER, 2002, 36 (01) : 43 - 48
  • [32] Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer
    Kreuter, Michael
    Vansteenkiste, Johan
    Herth, Felix J. F.
    Fischer, Juergen R.
    Eberhardt, Wilfried
    Zuna, Ivan
    Reinmuth, Niels
    Griesinger, Frank
    Thomas, Michael
    RESPIRATION, 2014, 87 (03) : 204 - 210
  • [33] A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
    Zhang, Zhenyang
    Xie, Shuhan
    Cai, Weijing
    Yang, Chuangcai
    Hong, Zhi-Nuan
    Lin, Yukang
    Zhu, Jiafu
    Lin, Zhiwei
    Christoph, Daniel C.
    Bohnenberger, Hanibal
    Kepka, Lucyna
    Brueckl, Wolfgang M.
    Van Houtte, Paul
    Kang, Mingqiang
    Lin, Jiangbo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (01) : 75 - +
  • [34] Comparing Outcomes of Neoadjuvant and Adjuvant Chemotherapy in Non-Small Cell Lung Cancer
    Sharma, Sandhya
    Bista, Amir
    Joshi, Abhash
    Charles, Kevin
    Lash, Bradley
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S571 - S571
  • [35] Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice
    Massard, Christophe
    Loc, Pierre Tran Ba
    Haddad, Vincent
    Pignon, Jean-Pierre
    Girard, Philippe
    Monnet, Isabelle
    Tredaniel, Jean
    Besse, Benjamin
    Soria, Jean-Charles
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1504 - 1510
  • [36] Adjuvant Chemotherapy After Complete Resection of Non-Small Cell Lung Cancer
    Laack, E.
    Bokemeyer, C.
    Hossfeld, D. K.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (14): : 249 - 254
  • [37] Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?
    Tiseo, M
    Franciosi, V
    Grossi, F
    Ardizzoni, A
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (01) : 8 - 16
  • [38] Optimal adjuvant therapy for non-small cell lung cancer - How to handle stage I disease
    Wakelee, Heather
    Dubey, Sarita
    Gandara, David
    ONCOLOGIST, 2007, 12 (03) : 331 - 337
  • [39] Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer
    Wang, Meng
    Zhao, Jing
    Su, Yan-Jun
    Zhao, Xiao-Liang
    Wang, Chang-Li
    ONCOLOGY LETTERS, 2012, 4 (06) : 1349 - 1353
  • [40] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
12345